Solorzano, C C
In vivo intracellular signaling as a marker of antiangiogenic activity. [electronic resource]
- Cancer research Oct 2001
- 7048-51 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0008-5472
Androstadienes--pharmacology
Angiogenesis Inhibitors--pharmacology
Biomarkers, Tumor--physiology
Blotting, Western
Endothelial Growth Factors--pharmacology
Endothelium, Vascular--drug effects
Enzyme Activation
Enzyme Inhibitors--pharmacology
Flavonoids--pharmacology
Fluorescent Antibody Technique
Humans
Indoles--pharmacology
Liver Neoplasms--blood supply
Lymphokines--pharmacology
MAP Kinase Signaling System--drug effects
Mitogen-Activated Protein Kinase Kinases--antagonists & inhibitors
Neovascularization, Pathologic--drug therapy
Oxindoles
Phosphatidylinositol 3-Kinases--metabolism
Phosphoinositide-3 Kinase Inhibitors
Phosphorylation
Propionates
Protein Serine-Threonine Kinases
Proto-Oncogene Proteins--antagonists & inhibitors
Proto-Oncogene Proteins c-akt
Pyrroles--pharmacology
Receptor Protein-Tyrosine Kinases--antagonists & inhibitors
Receptors, Growth Factor--antagonists & inhibitors
Receptors, Vascular Endothelial Growth Factor
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factors
Wortmannin